Digital communication company pharma industry for sale in Europe

• Revenue: > 3M EUR
• EBITDA: > 500K EURO
• Employees: > 50
• Location of the Digital communication company in pharma industry: Europe
• Reason for sale: The owners want to grow the company in Europe, therefore are looking to talk to interested investors
• #CFIE ITS200

The company is a market leader in a smaller European country at the moment. Considering the country it is active in, the company it is actually quite big and even one of the biggest communication companies in health from the respective region. However, the key potential lies in expanding into other markets which is far from being capitalized on to maximum potential. Maintaining the company structure small at the moment has been a strategic decision. The team is capable of doing highly innovative work in a digital world. The company is looking for a buyer that can help it expand all across Europe. A buyer can extend and grow this pharma experience across many more clients. An ideal buyer is active as a service provider in the pharma industry and due to this acquisition can help the company to grow across Europe or the Americas. A possible other buyer could be also involved in Mobile App development.

The company for sale represents a group of complementary enterprises active in advertising and digital communication for pharma clients. Each company is focused on areas such as PR and public affairs, blogging, influential marketing, brand strategy, web analytics, app development and events. The group is present in Europe and Latin America building a unique strategic vision and looking for new business and expansion. The company has a strong focus on the pharma industry and has many blue chip pharma clients in its portfolio. Part of its activity is represented by health marketing and communication, the concepts and the solutions developed and delivered through multi channels offer visible results. There is also software development plus UI/UX work the company does and all of this part is done part in-house. Mobile app development it is a fundamental component of what the company does. The revenue registered by the company can be allocated per each activity as it follows: Mobile App development 20%, Web development 40%, Content/Medical education (digital campaigns) 30%, Multi-media Events 0%, Advertising 10%.

Aside from health marketing and app development, the company provides also other communication channels such as patient compliance and education services, advertising, multichannel consulting, medical education, digital strategy and events. Part of digital strategy is represented by analysing and following the social media trends and taking the advantage of these trends in order to give a boost to the pharma and health client’s businesses by increasing the brand’s awareness. The multichannel consulting is based on the pharma market evolution and dynamics, the team observes the market trends, analyses the tendencies and for every project it identifies the right channel to transmit the message to the chosen target of clients.

The company for sale delivers the following services and solutions:

• Strategic Communication
• Health Marketing & Advertising
• Brand Strategy & Activation
• Multichannel Consulting
• App Development & Web Analytics
• Social Media Campaigns & Digital Strategy
• Medical & Patient Education & Compliance
• Pharma Content Development
• Corporate & Public Affairs
• KPI Monitoring
• Training
• Events

• The company is a group of complementary enterprises that are active digital communication services for pharma industry
• The company developed communication channels and tools that boost the pharma clients’ businesses
• The company delivers also app development services specific for health sector
• The owners are looking to talk with potential investors that are interested to grow the business in Europe